These data illustrate also the utility in the translation of the concept of seeking antagonists with functional selectivity respect to G-protein-independent and β-arr-dependent ET-1 signaling to block cellular responses associated with tumor progression [10]. The gene discussed is EDN1; the disease is neoplasm.